Your daily selection of the latest science news!
According to Medical Xpress (This article and its images were originally posted on Medical Xpress January 2, 2019 at 02:05PM.)
For decades, scientists have recognized that more males get cancer and die of the disease than females. This is true for many types of cancer, including the deadly brain tumor glioblastoma. Now, a team of researchers led by Washington University School of Medicine in St. Louis has identified distinct molecular signatures of glioblastoma in men and women that help explain such underlying disparities in patients’ response to treatment and survival.
The research suggests that tailoring treatments to men and women with glioblastoma based on the molecular subtypes of their tumors may improve survival for all patients.
The findings are published Jan. 2 in Science Translational Medicine.
- Got any news, tips or want to contact us directly? Feel free to email us: firstname.lastname@example.org.
To see more posts like these; please subscribe to our newsletter. By entering a valid email, you’ll receive top trending reports delivered to your inbox.